Clinical Trial Update: Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of OTX-DP for post-cataract ocular inflammation and pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ocular Inflammation and Pain Following Cataract Surgery

Drugs mentioned

• OTX-DP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Post Ocular Surgical Inflammation and Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-01-31